Xiao Zang

1.5k total citations
54 papers, 788 citations indexed

About

Xiao Zang is a scholar working on Epidemiology, Infectious Diseases and General Health Professions. According to data from OpenAlex, Xiao Zang has authored 54 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Epidemiology, 27 papers in Infectious Diseases and 16 papers in General Health Professions. Recurrent topics in Xiao Zang's work include HIV, Drug Use, Sexual Risk (25 papers), HIV/AIDS Research and Interventions (23 papers) and Opioid Use Disorder Treatment (13 papers). Xiao Zang is often cited by papers focused on HIV, Drug Use, Sexual Risk (25 papers), HIV/AIDS Research and Interventions (23 papers) and Opioid Use Disorder Treatment (13 papers). Xiao Zang collaborates with scholars based in United States, Canada and China. Xiao Zang's co-authors include Brandon D. L. Marshall, Bohdan Nosyk, Bruce R. Schackman, Yang Xie, Zhongju Zou, Rhea Sumpter, Yongjie Wei, Minfei Su, Zhenyi An and Sangita C. Sinha and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Xiao Zang

48 papers receiving 772 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiao Zang United States 15 416 219 148 142 112 54 788
James Y. Dai United States 18 173 0.4× 276 1.3× 65 0.4× 330 2.3× 117 1.0× 71 1.2k
Hsu‐Sung Kuo Taiwan 19 863 2.1× 179 0.8× 114 0.8× 83 0.6× 59 0.5× 28 1.4k
Anelisa Jaca South Africa 15 240 0.6× 202 0.9× 52 0.4× 63 0.4× 62 0.6× 38 797
Amy M. Sitapati United States 15 246 0.6× 192 0.9× 86 0.6× 35 0.2× 104 0.9× 33 635
Michael C. Jones United Kingdom 17 186 0.4× 69 0.3× 71 0.5× 107 0.8× 39 0.3× 45 938
Prithwish De Canada 22 468 1.1× 244 1.1× 178 1.2× 166 1.2× 124 1.1× 38 1.4k
Ke Wu China 22 150 0.4× 231 1.1× 51 0.3× 451 3.2× 63 0.6× 68 1.5k
Jeffrey Anderson United States 16 265 0.6× 142 0.6× 60 0.4× 109 0.8× 20 0.2× 46 851
Zhangkai J. Cheng China 12 96 0.2× 388 1.8× 60 0.4× 176 1.2× 52 0.5× 61 1.1k
Victor Lei United States 17 127 0.3× 41 0.2× 58 0.4× 152 1.1× 94 0.8× 34 989

Countries citing papers authored by Xiao Zang

Since Specialization
Citations

This map shows the geographic impact of Xiao Zang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao Zang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao Zang more than expected).

Fields of papers citing papers by Xiao Zang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao Zang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao Zang. The network helps show where Xiao Zang may publish in the future.

Co-authorship network of co-authors of Xiao Zang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao Zang. A scholar is included among the top collaborators of Xiao Zang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao Zang. Xiao Zang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zang, Xiao, et al.. (2025). Enumerating the State and Local Public Health Workforce During the COVID-19 Response. American Journal of Public Health. 115(5). 716–725.
2.
Leider, Jonathon P., et al.. (2025). Enumeration 2024: What We Know and What We Wish We Knew About the Governmental Public Health Workforce in a COVID-19 Recovery Landscape. American Journal of Public Health. 115(5). 707–715.
3.
Levengood, Timothy W., Xiao Zang, Bruce R. Schackman, et al.. (2025). A geospatial analysis of naloxone distribution patterns in the Massachusetts overdose education and naloxone distribution program (MA OEND). Drug and Alcohol Dependence. 274. 112783–112783. 1 indexed citations
4.
5.
Wang, Xing, et al.. (2025). Lycopene: a promising adjuvant to photodynamic therapy in oral cancer. Lasers in Medical Science. 40(1). 252–252.
6.
Ma, Junfeng, Wenlong Ren, Bin Zhang, et al.. (2024). Health and economic impacts of Vaccae vaccination incorporating active case finding in India and South Africa: a modelling study. SHILAP Revista de lepidopterología. 2(2). e001042–e001042. 1 indexed citations
7.
Piske, Micah, Bohdan Nosyk, Justin C. Smith, et al.. (2024). Ending the HIV Epidemic in Metropolitan Atlanta: a mixed‐methods study to support the local HIV/AIDS response. Journal of the International AIDS Society. 27(7). e26322–e26322. 4 indexed citations
8.
9.
Enns, Benjamin, Yi Sui, Micah Piske, et al.. (2024). Estimating the potential value of MSM‐focused evidence‐based implementation interventions in three Ending the HIV Epidemic jurisdictions in the United States: a model‐based analysis. Journal of the International AIDS Society. 27(S1). e26265–e26265. 1 indexed citations
10.
Zang, Xiao, Ting Jiang, Jian Feng, et al.. (2024). Health and Economic Impacts of Introducing Vaccae and Enhanced Drug-Resistant Tuberculosis Management Strategies in China. The Journal of Infectious Diseases. 231(5). 1271–1280. 1 indexed citations
11.
Chen, Zhixian, et al.. (2024). Modeling the epidemiologic impact of age-targeted vaccination for drug-resistant tuberculosis. Drug Resistance Updates. 78. 101172–101172.
12.
Zang, Xiao, et al.. (2023). Population-level health and economic impacts of introducing Vaccae vaccination in China: a modelling study. BMJ Global Health. 8(5). e012306–e012306. 7 indexed citations
13.
Jiang, Shan, Yitong Wang, Lei Si, et al.. (2022). Incorporating productivity loss in health economic evaluations: a review of guidelines and practices worldwide for research agenda in China. BMJ Global Health. 7(8). e009777–e009777. 24 indexed citations
14.
Jacka, Brendan, et al.. (2022). Brief Report: Use of Pre-Exposure Prophylaxis to Prevent Rapid HIV Transmission Among People Who Inject Drugs in Rural Counties in the United States: A Modeling Study. JAIDS Journal of Acquired Immune Deficiency Syndromes. 91(5). 449–452. 2 indexed citations
15.
Zang, Xiao, Avik Chatterjee, Czarina N. Behrends, et al.. (2021). Community‐based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode Island. Addiction. 117(5). 1372–1381. 12 indexed citations
16.
Wang, Haitao, et al.. (2021). Cost-effectiveness of human papillomavirus vaccine in China: a systematic review of modelling studies. BMJ Open. 11(12). e052682–e052682. 10 indexed citations
17.
18.
Jiang, Shan, Zhuo Chen, Jing Wu, Xiao Zang, & Yawen Jiang. (2020). Addressing methodological and ethical issues in practicing health economic evaluation in China. Journal of Global Health. 10(2). 20322–20322. 10 indexed citations
19.
20.
Luo, Xin, Xiao Zang, Lin Yang, et al.. (2016). Comprehensive Computational Pathological Image Analysis Predicts Lung Cancer Prognosis. Journal of Thoracic Oncology. 12(3). 501–509. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James Y. Dai Breakdown of academic impact, for papers by Hsu‐Sung Kuo Breakdown of academic impact, for papers by Anelisa Jaca Breakdown of academic impact, for papers by Amy M. Sitapati Breakdown of academic impact, for papers by Michael C. Jones Breakdown of academic impact, for papers by Prithwish De Breakdown of academic impact, for papers by Ke Wu Breakdown of academic impact, for papers by Jeffrey Anderson Breakdown of academic impact, for papers by Zhangkai J. Cheng Breakdown of academic impact, for papers by Victor Lei
Rankless by CCL
2026